Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Dynoodt

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Pigment Cell & Melanoma Research|February 27, 2009
Griscelli syndrome: a model system to study vesicular traffickingMireille Van Gele, Peter Dynoodt, Jo Lambert
Expert Review of Molecular Diagnostics|December 2, 2015
Prognostic and predictive biomarkers in melanoma: an updateMona Foth, Jasper Wouters, Ciaran de Chaumont, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 26, 2011
Lipid-mediated gene delivery to the skinBarbara Geusens, Tine Strobbe, Stefanie Bracke, et al.
International Journal of Oncology|February 14, 2013
miR-145 overexpression suppresses the migration and invasion of metastatic melanoma cellsPeter Dynoodt, Reinhart Speeckaert, Olivier De Wever, et al.
Experimental Dermatology|June 29, 2011
Development of a 3D pigmented skin model to evaluate RNAi-induced depigmentationMireille Van Gele, Barbara Geusens, Reinhart Speeckaert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 24, 2019
Validation of the OncoMasTR Risk Score in Estrogen Receptor-Positive/HER2-Negative Patients: A TransATAC studyRichard Buus, Ivana Sestak, Stephen Barron, et al.
The Journal of Investigative Dermatology|August 17, 2012
Identification of miR-145 as a key regulator of the pigmentary processPeter Dynoodt, Pieter Mestdagh, Gert Van Peer, et al.
Cell Death & Disease|February 15, 2020
Low expression of pro-apoptotic proteins Bax, Bak and Smac indicates prolonged progression-free survival in chemotherapy-treated metastatic melanomaCristiano Guttà, Arman Rahman, Claudia Aura, et al.
BMC Medicine|June 6, 2017
Comprehensive DNA methylation study identifies novel progression-related and prognostic markers for cutaneous melanomaJasper Wouters, Miguel Vizoso, Anna Martinez-Cardus, et al.
Clinical Chemistry|March 21, 2022
Analytical Validation of a Novel 6-Gene Signature for Prediction of Distant Recurrence in Estrogen Receptor-Positive, HER2-Negative, Early-Stage Breast CancerTony Loughman, Stephen Barron, Chan-Ju Angel Wang, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Pigment Cell & Melanoma Research|February 27, 2009
Griscelli syndrome: a model system to study vesicular traffickingMireille Van Gele, Peter Dynoodt, Jo Lambert
Expert Review of Molecular Diagnostics|December 2, 2015
Prognostic and predictive biomarkers in melanoma: an updateMona Foth, Jasper Wouters, Ciaran de Chaumont, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 26, 2011
Lipid-mediated gene delivery to the skinBarbara Geusens, Tine Strobbe, Stefanie Bracke, et al.
International Journal of Oncology|February 14, 2013
miR-145 overexpression suppresses the migration and invasion of metastatic melanoma cellsPeter Dynoodt, Reinhart Speeckaert, Olivier De Wever, et al.
Experimental Dermatology|June 29, 2011
Development of a 3D pigmented skin model to evaluate RNAi-induced depigmentationMireille Van Gele, Barbara Geusens, Reinhart Speeckaert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 24, 2019
Validation of the OncoMasTR Risk Score in Estrogen Receptor-Positive/HER2-Negative Patients: A TransATAC studyRichard Buus, Ivana Sestak, Stephen Barron, et al.
The Journal of Investigative Dermatology|August 17, 2012
Identification of miR-145 as a key regulator of the pigmentary processPeter Dynoodt, Pieter Mestdagh, Gert Van Peer, et al.
Cell Death & Disease|February 15, 2020
Low expression of pro-apoptotic proteins Bax, Bak and Smac indicates prolonged progression-free survival in chemotherapy-treated metastatic melanomaCristiano Guttà, Arman Rahman, Claudia Aura, et al.
BMC Medicine|June 6, 2017
Comprehensive DNA methylation study identifies novel progression-related and prognostic markers for cutaneous melanomaJasper Wouters, Miguel Vizoso, Anna Martinez-Cardus, et al.
Clinical Chemistry|March 21, 2022
Analytical Validation of a Novel 6-Gene Signature for Prediction of Distant Recurrence in Estrogen Receptor-Positive, HER2-Negative, Early-Stage Breast CancerTony Loughman, Stephen Barron, Chan-Ju Angel Wang, et al.
Pageof 2